放射性皮肤损伤的中西医研究进展  

Research progress of Chinese and Western medicine of radiation-induced dermatitis

作　　者：郭倩蓉 孙研 祝金标 吴勉华[2] GUO Qianrong;SUN Yan;ZHU Jinbiao;WU Mianhua(The First Clinical College,Nanjing University of Chinese Medicine,Nanjing 20023,China;Jiangsu Cllaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor,Nanjing University of Chinese Medicine,Nanjing 210023,China)

机构地区：[1]南京中医药大学第一临床医学院,南京210023 [2]南京中医药大学江苏省中医药防治肿瘤协同创新中心,南京210023

出　　处：《中华中医药杂志》2025年第3期1302-1306,共5页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：吴勉华全国名老中医药专家传承工作室(No.国中医药人教函【2022】75号);第二届全国名中医传承工作室(No.国中医药办人教函【2022】245号);国家中医药管理局第七批全国老中医药专家学术经验继承工作项目(No.国中医药人教函【2022】76号);吴勉华江苏省名老中医药专家传承工作室(No.苏中医科教【2021】7号);国家中医药管理局中医药传承与创新“百千万”人才工程(岐黄工程)岐黄学者项目(No.国中医药人教函【2018】284号)。

摘　　要：放射性皮肤损伤(RID)是放射治疗的常见不良反应之一,损伤达到3级则需暂停放疗,给患者造成了心理和经济压力,甚者可导致整体病情恶化。近年来,RID的研究不曾间断,在影响因素、评价标准、发病机制、中西医治法等方面均有新的成果。笔者将近5年RID的中西医研究进展进行综述,最终认为何种剂型既能最大限度发挥中药药效又不影响放疗是未来需要关注的方向,并提出对于剂型选择的思考,以期为临床治疗及后续研究提供参考。Radiation-induced dermatitis(RID)is one of the common side effects of radiotherapy,and if the injury reaches grade 3,radiotherapy needs to be suspended,which causes psychological and financial pressure to patients,and can even lead to the deterioration of the overall condition.In recent years,the research on RID has been uninterrupted,and new achievements have been made in terms of influencing factors,evaluation criteria,pathogenesis,and traditional Chinese and Western medical treatments.The author reviews the RID research progress of traditional Chinese and Western medicine in the past five years,and finally believes that which dosage form can maximize the efficacy of traditional Chinese medicine without affecting radiotherapy is the direction that needs to be paid attention to in the future,and puts forward thoughts on the choice of dosage form,in order to provide reference for clinical treatment and follow-up research.

关 键 词：放射性皮肤损伤 中医药 剂型 外治法 综述 

分 类 号：R730.55[医药卫生—肿瘤]